1. Australian Government Department of Health and Ageing. The national strategy for quality use of medicines. Commonwealth of Australia, Canberra, 2002. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/nmp-pdf-natstrateng-cnt.htm/$FILE/natstrateng.pdf . Accessed Oct 2004.
2. Government of New South Wales. Poisons and therapeutic goods act 1966, 2004. http://www.legislation.nsw.gov.au/maintop/scanact/inforce/NONE/0
3. National Coordinating Committee on Therapeutic Goods (NCCTG). A report to the Australian health ministers’ conference on the results of the research into a cost-benefit analysis and risk assessment of pharmacist only (S3) and pharmacy medicines (S2) and risk-based evaluation of the standards. Canberra: Australian Government Department of Health and Ageing; 2005.
4. Australian Self-Medication Industry. Self care in Australia: the foundation for a healthy nation. 2005. http://www.asmi.com.au
5. Therapeutic Goods Administration. NDPSC Record of reasons. 2003. http://www.health.gov.au/tga/ndpsc/records.htm